Secondary Lymphedema Segment to Account for Maximum Market Share During 2021-2028

According to our latest study on "Lymphedema Treatment Market Size and Forecast to 2028 - COVID-19 Impact and Global Analysis - by Condition Type, Treatment Type, and End-User," the market is projected to reach US$ 11.58 billion by 2028 from US$ 8.15 billion in 2021; it is expected to grow at a CAGR of 5.1% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the lymphedema treatment market.

Market Overview

Occupational health aims to protect the physical, mental, and overall wellbeing of employees in the workplace, with the goal of preventing work-related illnesses, injuries, and stress. Certain work environments can expose employees to harmful chemicals and surroundings that can lead to serious disorders like cancer and asthma. Occupational medicine provides a systematic approach to preventing and managing such disorders.

Market Segmentation

The lymphedema treatment market is categorized by condition type, including primary lymphedema and secondary lymphedema. In 2020, the secondary lymphedema segment dominated the lymphedema treatment market and is expected to maintain its position during the forecast period. However, the primary lymphedema segment is predicted to experience significant growth during the forecast period. Secondary lymphedema is a challenging complication linked with breast cancer treatment that results in unfavorable physical and psychological effects, according to the American Society of Clinical Oncology report. The prevalence of breast cancer is typically estimated at around 30%, varying from 2% to 83%. Additionally, 24-49% of cancer patients may develop secondary lymphedema following cancer therapy, according to the Frontiers S.A. report.   The lymphedema treatment market is categorized by treatment type into laser therapy, compression devices and bandaging, drug therapy, physiological procedures, debulking procedures, and others. Physiological procedures are divided into lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT), while debulking procedures are divided into surgical debulking, liposuction, and others. The lymphedema treatment market is categorized by end-user as hospitals, clinics, clinical research organizations, and others. In terms of geography, the lymphedema treatment market is divided into North America (including the US, Canada, and Mexico), Europe (including France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (including China, India, Japan, Australia, South Korea, and Rest of APAC), MEA (including Saudi Arabia, UAE, South Africa, and Rest of MEA), and South and Central America (including Brazil, Argentina, and Rest of South and Central America).

Market Dynamics

The demand for lymphedema treatment is expected to increase due to recent technological advancements in compression bandaging. Recent technological advancements in the compression bandaging category are driving the lymphedema treatment market growth by providing more effective and convenient treatment options for patients. For example, some compression bandaging systems now incorporate built-in pressure systems that ensure proper compression throughout use, making it easier for patients to manage their condition. Additionally, some systems have user-friendly designs that enable patients to achieve their compression needs for the treatment and management of chronic venous disease and lymphedema. These technological advancements have improved the patient experience and increased treatment compliance, resulting in better clinical outcomes and increased demand for lymphedema treatment. Circaid's built-in pressure system card offers a user-friendly design that allows patients to meet their compression needs for the treatment and management of chronic venous disease and lymphedema, with consistent compression range. However, the COVID-19 pandemic has resulted in canceled physician appointments and subsequent delays in hospital visits.

Market Companies

The global lymphedema treatment market is led by several prominent companies such as BIOCOMPRESSION SYSTEMS, Tactile Medical, Smith and Nephew, BSN Medical GmbH, Lohmann & Rauscher GmbH & Co. KG, SIGVARIS GROUP, ThermoTek, Huntleigh Healthcare Limited, 3M, and Mego Afek Ltd.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com